Laura Barthe-Padron

Global Health Medicines R&D
Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

High-throughput screening of small molecules targeting Mycobacterium tuberculosis in human iPSC macrophages.

High-throughput screening of small molecules targeting Mycobacterium tuberculosis in human iPSC macrophages.

Journal: Antimicrobial agents and chemotherapy

Published: May 27, 2025

Early Preventive Treatment With Enalapril Improves Cardiac Function and Delays Mortality in Mice With Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.

Early Preventive Treatment With Enalapril Improves Cardiac Function and Delays Mortality in Mice With Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.

Journal: Circulation. Heart failure

Published: August 20, 2021

Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β.

Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β.

Journal: Circulation

Published: October 01, 2019

Correction to: Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data.

Correction to: Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data.

Journal: Journal of cardiovascular translational research

Published: July 17, 2019

Genetic Etiology for Alcohol-Induced Cardiac Toxicity.

Genetic Etiology for Alcohol-Induced Cardiac Toxicity.

Journal: Journal of the American College of Cardiology

Published: January 05, 2018

Activation of Serine One-Carbon Metabolism by Calcineurin Aβ1 Reduces Myocardial Hypertrophy and Improves Ventricular Function.

Activation of Serine One-Carbon Metabolism by Calcineurin Aβ1 Reduces Myocardial Hypertrophy and Improves Ventricular Function.

Journal: Journal of the American College of Cardiology

Published: July 23, 2017

Animal models of arrhythmogenic right ventricular cardiomyopathy: what have we learned and where do we go? Insight for therapeutics.

Animal models of arrhythmogenic right ventricular cardiomyopathy: what have we learned and where do we go? Insight for therapeutics.

Journal: Basic research in cardiology

Published: April 07, 2017

Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.

Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.

Journal: PloS one

Published: March 22, 2017

Retraction: Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence.

Retraction: Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence.

Journal: Nature communications

Published: March 08, 2017

Role of echocardiography in the diagnosis and management of hypertrophic cardiomyopathy.

Role of echocardiography in the diagnosis and management of hypertrophic cardiomyopathy.

Journal: Heart (British Cardiac Society)

Published: January 12, 2017

Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice.

Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice.

Journal: Cardiovascular research

Published: January 05, 2017

Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data.

Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data.

Journal: Journal of cardiovascular translational research

Published: October 12, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026